Bellicum Pharmaceuticals Company
Bellicum is engineering high-performance cellular immunotherapies and unleashing their power against a wide range of cancers, impacting more patients than ever.
Industry:
Genomic and Epigenominc Instabillity
Technology:
Сancer Diagnostics
Funding Status:
IPO
Estimated Revenue:
Less than $1M
Headquarters:
United States
Founded Date:
01.07.2004